Professor Marion MacFarlane
- Deputy Director
- MRC Investigator
Contact
Connect
About
Marion MacFarlane is Deputy Director of the MRC Toxicology Unit and Programme lead for the Molecular mechanisms of cell death Programme and the cross-Unit Fibre Toxicity Programme
Biography:
2011-Present Deputy Director, MRC Toxicology Unit
2004-Present Programme Leader, MRC Toxicology Unit
2011-Present Honorary Chair, Dept. of Molecular & Cell Biology, University of Leicester
1998-2004 MRC Programme Leader-Track Scientist, MRC Toxicology Unit
1997-1998 MRC Visiting Research Fellow, Kimmel Cancer Centre, Philadelphia, USA
1992-1997 Senior Postdoctoral Research Fellow, MRC Toxicology Unit
1989-1992 Wellcome Trust Advanced Training Fellowship Award, University of Surrey
1989 PhD (University of Surrey) Biochemistry – BBSRC-funded iCASE with AstraZeneca
1985 BSc Hons (University of Glasgow) Pharmacology
Research Interests:
Unit Programme: Molecular Mechanisms of Cell Death
Cell death is a fundamental cellular response that plays a crucial role both during development and in the removal of unwanted or damaged cells following stress, injury or infection. Consequently, cell death is tightly controlled and often occurs in an ordered manner by a process called ‘apoptosis’, or another more recently identified mode of regulated cell death termed ‘necroptosis’. Inappropriate cell death contributes to many human diseases, including cancer, autoimmune and neurodegenerative disorders. Proteins/pathways that control cell death have also been identified as defined nodes that form key decision points to regulate the response to toxic insult.
Our programme is aimed at understanding the fundamental mechanisms of cell death that regulate life/death decisions at the cellular level. By understanding the underlying molecular and cell biology of these processes, we aim to deliver field-changing mechanistic insights into toxicology and disease.
We are investigating:
- Cell death pathways activated in response to a range of agents, with a focus on members of the Tumour Necrosis Factor (TNF) cytokine family
- Drugs or other xenobiotics that trigger mitochondrial-mediated cell death
- Cell death pathways induced by some Anti-Sense Oligonucleotide (ASO) /other nucleic acid-dependent therapeutics under development
Our recent work places multiprotein signalling complexes triggered by members of the TNF cytokine family as key determinants of cell death (apoptosis or necroptosis) or survival (pro-inflammatory). We deploy strategies including novel in vitro reconstituted models, combined with an integrated molecular, cell biology, proteomics and structural biology-based approach to obtain novel insights into the assembly, regulation and molecular architecture of these multiprotein signalling complexes that direct cell fate.
Off-target inhibition of mitochondrial function is a key contributor to drug attrition and a major driver of tissue-specific hepatotoxicity and cardiotoxicity. We are investigating mechanisms of drug-induced mitochondrial toxicity or cell adaptation in translational models of hepatotoxicity/cardiotoxicity and, building on our recent work showing that drug ‘toxicophores’ result in off-target inhibition of the electron transport chain, we are integrating high-throughput analysis of drug/xenobiotic perturbation of mitochondrial health with active Machine Learning to identify novel features linked to mitochondrial toxicity.
Data obtained via these integrated approaches will provide novel insights into the fundamental mechanisms of cell death, providing mechanistic frameworks to inform safer drug development and strategies for safer medicine use based on modelling individual variability.